Epitope mapping for the anti-rabbit cholesteryl ester transfer protein monoclonal antibody that selectively inhibits triglyceride transfer

Journal of Lipid Research

Volumn 40, Issue 11, 1999, Pages 2013-2021

  Saito, Kazunori ^a   Kobori, Ki Ichiro ^a   Hashimoto, Hideyuki ^a   Ito, Sachiko ^a   Manabe, Mitsuhisa ^a   Yokoyama, Shinji ^b  

^a Diagnostics Research Laboratories   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Cholesteryl ester; Cholesteryl ester transfer protein; Epitope; Monoclonal antibody; Triglyceride

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; CROSS REACTING ANTIBODY; EPITOPE; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT; SYNTHETIC PEPTIDE; TRIACYLGLYCEROL;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; EPITOPE MAPPING; FATTY ACID TRANSPORT; HYBRIDOMA; LIPID TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN LIPID INTERACTION; RABBIT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; BINDING SITES; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CIRCULAR DICHROISM; EPITOPE MAPPING; EPITOPES; GLYCOPROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; RABBITS; TRIGLYCERIDES;

EID: 0032746130     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Tall, A. R. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274.
2. Lagrost, L. 1994. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim. Biophys. Acta. 1215: 209-236.
3. Tall, A. R. 1995. Plasma lipid transfer proteins. Annu. Rev. Biochem. 64: 235-257.
4. Agellon, L. B., A. Walsh, T. Hayek, P. Moulin, X. C. Jiang, S. A. Shelanski, J. L. Breslow, and A. R. Tall. 1991. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J. Biol. Chem. 266: 10796-10801.
5. Morton, R. E., and D. B. Zilversmit. 1983. Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J. Biol. Chem. 258: 11751-11757.
6. Ko, K. W. S., T. Ohnishi, and S. Yokoyama. 1994. Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein: Evidence for a hetero-exchange transfer mechanism demonstrated by using novel monoclonal antibodies. J. Biol. Chem. 269: 28206-28213.
7. Hayek, T., N. Azrolan, R. B. Verdery, A. Walsh, T. Chajek-Shaul, L. B. Agellon, A. R. Tall, and J. L. Breslow. 1993. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism: Studies in transgenic mice. J. Clin. Invest. 92: 1143-1152.
8. Föger, B., A. Ritsch, A. Doblinger, H. Wessels, and J. R. Patsch. 1996. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol: Studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler. Thromb. Vasc. Boil. 16: 1430-1436.
9. Inazu, A., M. L. Brown, C. B. Hesler, L. B. Agellon, J. Koizumi, K. Takata, Y. Maruhama, H. Mabuchi, and A. R. Tall. 1990. Increased high-density lipoprotein levels caused by common cholesteryl ester transfer protein gene mutation. N. Engl. J. Med. 323: 1234-1238.
10. Swenson, T. L., C. B. Hesler, M. L. Brown, E. Quinet, P. P. Trotta, M. F. Haslanger, F. C. A. Gaeta, Y. L. Marcel, R. W. Milne, and A. R. Tall. 1989. Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope. J. Biol. Chem. 264: 14318-14326.
11. Roy, P., R. MacKenzie, T. Hirama, X-C. Jiang, P. Kussie, A. Tall, E. Rassart, and R. Milne. 1996. Structural-function relationships of human cholesteryl ester transfer protein: analysis using monoclonal antibodies. J. Lipid Res. 37: 22-34.
12. Wang, S., L. Deng, R. W. Milne, and A. R. Tall. 1992. Identification of a sequence within the C-terminal 26 amino acids of cholesteryl ester transfer protein responsible for binding a neutralizing monoclonal antibody and necessary for neutral lipid transfer activity. J. Biol. Chem. 267: 17487-17490.
13. Wang, S., X. Wang, L. Deng, E. Rassart, R. W. Milne, and A. R. Tall. 1993. Point mutagenesis of carboxyl-terminal amino acids of cholesteryl ester transfer protein: Opposite faces of an amphipathic helix important for cholesteryl ester transfer or for binding neutralizing antibody. J. Biol. Chem. 268: 1955-1959.
14. Wang, S., P. Kussie, L. Deng, and A. Tall. 1995. Defective binding of neutral lipids by carboxyl-terminal deletion mutant of cholesteryl ester transfer protein. J. Biol. Chem. 270: 612-618.
15. Ohnishi, T., C. Tan, and S. Yokoyama. 1994. Selective transfer of cholesteryl ester over triglyceride by human plasma lipid transfer protein between apolipoprotein-activated lipid microemulsion. Biochemistry. 33: 4533-4542.
16. Ohnishi, T., R. Oikawa, C. M. Kay, and S. Yokoyama. 1995. Modulation of substrate selectivity in plasma lipid transfer protein reaction over structural variation of lipid particle. Biochim. Biophys. Acta. 1254: 117-128.
17. Main, L. A., R. Okumura-Noji, and S. Yokoyama. 1998. Cholesteryl ester transfer protein reaction between plasma lipoproteins. J. Biochem. 124: 237-243.
18. Kushwaha, R. S., D. L. Rainwater, M. C. Williams, G. S. Getz, and H. C. J. McGill. 1990. Impaired plasma cholesteryl ester transfer with accumulation of larger high density lipoproteins in some families of baboons (Papio sp.). J. Lipid Res. 31: 965-973.
19. Melchior, G. W., K. A. Greenlee, C. K. Castle, M. J. Prough, R. W. Milne, R. R. Marotti, and F. J. Kézdy. 1995. Evidence that cynomologus monkey cholesteryl ester transfer protein has two neutral lipid binding sites. J. Biol. Chem. 270: 21068-21074.
20. Morton, R. E., and D. B. Zilversmit. 1982. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J. Lipid Res. 23: 1058-1067.
21. Fukazawa, M., H. Arai, and K. Inoue. 1992. Establishment of antihuman cholesteryl ester transfer protein monoclonal antibodies and radioimmunoassaying of the level of cholesteryl ester transfer protein in human plasma. J. Biochem. 111: 696-698.
22. Kotake, H., L. B. Agellon, and S. Yokoyama. 1997. Modification of the N-terminal cysteine of plasma cholesteryl ester transfer protein selectively inhibits triglyceride transfer activity. Biochim. Biophys. Acta. 1347: 69-74.
23. Epps, D. E., K. A. Gleenlee, J. S. Harris, E. W. Thomas, C. K. Castle, J. F. Fisher, R. R. Hozak, C. K. Marschle, G. W. Melchior, and F. J. Kézdy. 1995. Kinetics and inhibition of exchange catalyzed by plasma cholesteryl ester transfer protein (lipid transfer protein). Biochemistry. 34: 12560-12569.
24. Beamer, L. J., S. F. Carroll, and D. Eisenberg. 1997. Crystal structure of human BPI and two bound phospholipids at 2.4 Angstrom resolution. Science. 276: 1861-1864.
25. Bruce, C., L. J. Beamer, and A. R. Tall. 1998. The implications of the structure of the bactericidal/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein. Curr. Opin. Struct. Biol. 8: 426-434.
26. Hesler, B. C., A. R. Tall, T. L. Swenson, P. K. Weech, Y. L. Marcel, and R. W. Milne. 1988. Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J. Biol. Chem. 263: 5020-5023.
27. Yen, F. T., R. J. Deckelbaum, C. J. Mann, Y. L. Marcel, R. W. Milne, and A. R. Tall. 1989. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody: effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J. Clin. Invest. 83: 2018-2024.
28. Nakae, P. K., and A. Wawaoi. 1974. Peroxidase-labeled antibody. A new method of conjugation. J. Histochem. Cytochem. 22: 1084-1091.
29. Firede, M., S. Denery, J. Neimark, S. Kieffer, H. Gausepohl, and J. P. Briand. 1992. Incomplete TFA deprotection of N-terminal trityl-asparagine residue in fmoc solid-phase peptide chemistry. Pept. Res. 5: 145-147.
30. Neimark, J., and J. P. Briand. 1993. Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Pept. Res. 6: 219-228.
31. Benkirane, N., M. Friede, G. Guichard, J-P. Briand, M. H. V. Van Regenmortal, and S. Muller. 1993. Antigenicity and immunogenicity of modified synthetic peptides containing d-amino acid residues: Antibodies to a d-enantiomer do recognize the parent 1-hexapeptide and reciprocally. J. Biol. Chem. 268: 26279-26285.
32. Ball, J. M., N. L. Henry, R. C. Montelaro, and M. J. Newman. 1994. A versatile synthetic peptide-based ELISA for identifying antibody epitopes. J. Immunol. Methods. 171: 37-44.
33. Ohnishi, T., S. Yokoyama, and A. Yamamoto. 1990. Rapid purification of human plasma lipid transfer protein. J. Lipid Res. 31: 394-406.
34. Chen, Y. H., J. T. Yang, and H. M. Martinez. 1972. Determination of the secondary structures of proteins by circular dichroism and optical rotatory. Biochemistry. 11: 4120-4131.
35. Drayna, D., A. S. Jarnagin, J. McLean, W. Henzel, W. Kohr, C. Fielding, and R. Lawn. 1987. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature. 327: 632-634.
36. Nagashima, M., J. W. McLean, and R. M. Lawn. 1988. Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein. J. Lipid Res. 29: 1643-1649.
37. Kotake, H., Q. Li, T. Ohnishi, K. W. S. Ko, L. B. Agellon, and S. Yokoyama. 1996. Expression and secretion of rabbit plasma cholesteryl ester transfer protein by Pichia pastoris. J. Lipid Res. 37: 599-605.
38. Ko, K. W. S., K. Oikawa, T. Ohnishi, C. M. Kay, and S. Yokoyama. 1993. Purification, characterization and conformational analysis of rabbit plasma lipid transfer protein. Biochemistry. 32: 6729-6736.
39. Ohnishi, T., L. H. Hicks, K. Oikawa, C. M. Kay, and S. Yokoyama. 1994. Properties of human plasma lipid transfer protein in aqueous solution and at interfaces. Biochemistry. 33: 6093-6099.